Serum tissue polypeptide antigen (TPA): Monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2609-2613

  Bennink, R ^b   Van Poppel, H ^b   Billen, J ^b   Decoster, M ^b   Baert, L ^a   Mortelmans, L ^b   Blanckaert, N ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NONE

Author keywords

Bladder cancer; Tissue polypeptide antigen; Tumor marker

Indexed keywords

CYTOKERATIN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROLIFIGEN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ACCURACY; BLADDER CANCER; BLOOD LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION FUNCTION; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ANTIBODIES; ANTIBODIES, MONOCLONAL; CARCINOMA, TRANSITIONAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNORADIOMETRIC ASSAY; KERATINS; MALE; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0032805588     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Björklund B, Björklund V- Antigenicity of pooled human malignant and normal tissue by cyto-immunological technique: presence of an insoluble heat-labile tumor antigen. Int Arch Allergy 10: 153-847, 1957.
2. Björklund B, Lundblad G, Björklund V: Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique: II. Nature of tumor antigen. Int Arch Allergy 12: 241-61, 1958.
3. Björklund B: On the nature and clinical use of tissue polypeptide antigen (TPA). Tumor Diagnostik 1: 9-20, 1980.
4. Maulard C, Toubert ME, Chretien Y, et al: Serum tissue polypeptide antigen (S-TPA) in bladder cancer as a tumor marker. A prospective study. Cancer 73: 394-398, 1994.
5. Adolphs HD, Oehr P: Significance of plasma tissue polypeptide antigen determination for diagnosis and follow-up of urothelial bladder cancer. Urol Res 12: 125-128, 1984.
6. Khanna OP, Wer B: Tissue polypeptide antigen (TPA) as a predictor for genito- urinary cancers and their metastases. Urology 30: 106-110, 1987.
7. Filella X, Mendez V, Molina R, et al: TPA prognostic value in superficial bladder cancer. Anticancer Res 16: 2173-2176, 1996.
8. Van Poppel H, Billen J, Goethuys H, et al: Serum tissue polypeptide antigen (TPA) as a tumor marker for bladder cancer. Anticancer Res 16: 2205-2208, 1996.
9. Prolifigen TPA IRMA instructions for use. Sangtec Medical Sweden.
10. Sundstrom BE, D'Amico Y, Brundell : Development of a new Prolifigen TPA IRMA assay using monoclonal anti-cytokeratin antibodies. Int J Biol Markers 10: 166-173, 1995.
11. Prolifigen TPA-M IRMA instructions for use. Sangtec Medical Sweden.
12. Sundstrom BE, Stigbrand TI: Cytokeratins and tissue polypeptide antigen. Int J Biol Markers 9: 102-108, 1994.
13. Fuchs E, Weber K: Intermediate filaments: Structure, dynamics, function and disease. Ann Rev Bioch 63: 345-382, 1994.
14. Moll R, Francke WW, Schiller D, et al: The catalog of human cytokeratins: pattern of expression in normal epithelia, tumors and cultured cells - review. Cell 31: 11-24, 1982.
15. Osborn M, Weber K: Intermediate filaments: cell-type-specific markers in differentiation and pathology. Cell 31: 303-306, 1982.
16. Steinert PM, Roop DR: Molecular and cellular biology of intermediate filaments. Ann Rev Biochem 57: 593-625, 1988.
17. Francke WW, Weber K, Osborn M, et al: Antibody to prekeratin: decoration of tonofilament-like arrays in various cells of epithelial character. Exp Cell Res 116: 429-45, 1978.
18. Moll R, Schiller DL, Francke WW: Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol 111: 567-580, 1990.
19. Quinlan RA, Schiller DL, Hatzfeld M, et al: Patterns of expression and organization of cytokeratin intermediate filaments. Ann NY Acad Sci 42: 411-419, 1985.
20. Traub P: In Intermediate filaments. A review. Berlin Heidelberg. Springer Verlag, 1985.
21. Osborn M, Weber K: Intermediate filament proteins: a multigene family distinguishes major cell lineages. Trends Biochem Sci 11: 469-472, 1986.
22. Nathrath WB, Heidenkummer P, Björklund V, et al: Distribution of tissue polypeptide (TPA) in normal human tissues: immunohistochemical study on unfixed, methanol-, ethanol-, and formalin-fixed tissues. J Histochem Cytochem 33: 99-109, 1985.
23. Lüning B, Redelius O, Wiklund B, Björklund B: Chemical studies of TPA. In: Peeters H, ed. Protides Biol Fluids Proc Colloq 24. Oxford: Pergamon Press, 513-520, 1975.
24. Lüning B, Redelius P, Wiklund B, Björklund B: Biochemistry of TPA. In: Fishman WH, Sell S, eds. Onco-developmental gene expression. New York: Academic Press, 773-777, 1975.
25. Lüning B, Redelius P, Björklund B: Amino acid sequence identity of TPA fragments from different sources. In: Peeters H, ed. Protides Biol Fluids Proc Colloq 27. Oxford: Pergamon Press, 67-69, 1979.
26. Lüning B, Wiklund B, Redelius P, Björklund B: Biochemical properties of tissue polypeptide antigen. Biochim Biophys Acta 624: 90-101, 1980.
27. Lüning B, Nilsson U: Sequence homology between tissue polypeptide antigen (TPA) and intermediate filaments (IF) proteins. Acta Chem Scand B 37: 731-733, 1983.
28. Kirsch J, Oehr P, Winkler C: Localization of tissue polypeptide antigen in interphase HeLa cells by immunofluorescence microscopy. Tumordiagn Ther 4: 189-228, 1983.
29. Kirsch J, Oehr P, Winkler C: Display of TPA in interphase and mitosis. In Peeters H, ed. Protides Biol Fluids Proc Colloq 32. Oxford: Pergamon Press, 723-726, 1984.
30. Kirsch J, Oehr P, Winkler C: Localization of tissue polypeptide antigen in HeLa cells during mitosis as revealed by immunofluorescence microscopy. Tumordiagn Ther 5: 122-126, 1984.
31. Weber K, Osborn M, Moll R, et al: Tissue polypeptide antigen (TPA) is related to the non epidermal keratins 8, 18 and 19 typical of simple and non-squamous epithelia: re-evaluation of a human tumor marker. EMBO J 3: 2707-2714, 1984.
32. Moll R: Epithelial tumor markers: cytokeratins and tissue polypeptide antigen (TPA). Curr Top Pathol 77: 71-101, 1987.
33. Mellerick DM, Osborn M, Weber K: On the nature of serological tissue polypeptide antigen (TPA); monoclonal keratin 8, 18 and 19 antibodies react differently with TPA prepared from human cultured carcinoma cells and TPA in human serum. Oncogene 5: 1007-1017, 1990.
34. Pfaff M, O'Conner R, Vollmers HP, Muller-Hermelink HK: Human monoclonal antibody against a tissue polypeptide antigen-related protein from a patient with a signet-ring cell carcinoma ofthe stomach. Cancer Res 50: 5192-5198, 1990.
35. Luning B: New aspects on the specificity oftumor marker TPA. Lab Med 8: 445, 1984.
36. Oehr P, Vogel J: TPA release from cells: Mechanism for induction of elevated plasma levels in patient with TPA positive tumors. Proceed. 12th Ann Meet ISOBM, Houston, Texas, October 1984 Abstr 106.
37. Vangsted AJ: Serological tumor markers for small cell lung cancer and their therapeutic implication. APMIS 102: 561-580, 1994.
38. Luthgens M, Schlegel G: The clinical value of tissue polypeptide antigen (TPA): A review. J Tumor Marker Oncol 2: 261-271, 1987.
39. Barillari P, De Angelo F, Ramacciato G, et al: The role of CEA, TPA, and CA 199 in theearlydetectionofrecurrentgastriccancer. Cancer J 3: 139-142, 1990.
40. Kumar S, Costello CB, Glashan RW, Björklund RB: The clinical significance of tissue polypeptide antigen (TPA) in the urine of bladder cancer patients. Br J Urol 53: 578-581, 1981.
41. Carbin BE, Ekman P, Eneroth P, Nilsson B: Urine-TPA (tissue polypeptide antigen) flowcytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma. Urol Res 17: 269-272, 1989.